Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

CEO Dig Howitt highlighted a 6% increase in net sales on a constant currency basis, driven by 13% growth in Cochlear implant revenue and 22% growth in Acoustics revenue. Services revenue declined by ...

In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$240.00. The company’s shares closed ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

In a report released on February 14, David Low from J.P. Morgan upgraded Cochlear Limited (CHEOF – Research Report) to a Buy, with a price target of A$311.00. The company’s shares closed last Friday ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ -- In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the ...

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...